NYSE: RMDResmed Revenue
Resmed revenue was $5.26B for the trailing 12 months ending Sep 30, 2025, with 29.8% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $1.3B, down 0.9% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, RMD annual revenue was $5.1B, with 9.8% growth year-over-year.
RMD past revenue growth
How has RMD's revenue growth performed historically?
Company
9.36%
Industry
13.72%
Market
22.05%
RMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
RMD revenue history
Current Revenue
$5.3B
Current Earnings
$1.4B
Current Profit Margin
27.4%
RMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when RMD announces revenue.
RMD Revenue History By Year
| RMD Yearly Revenue | RMD Revenue | RMD Change | RMD Revenue Growth |
|---|---|---|---|
| 2025-06-30 | $5.15B | $461.03M | +9.84% |
| 2024-06-30 | $4.69B | $462.30M | +10.95% |
| 2023-06-30 | $4.22B | $644.87M | +18.02% |
| 2022-06-30 | $3.58B | $381.30M | +11.93% |
| 2021-06-30 | $3.20B | $239.81M | +8.11% |
| 2020-06-30 | $2.96B | $350.44M | +13.44% |
| 2019-06-30 | $2.61B | $266.38M | +11.38% |
| 2018-06-30 | $2.34B | $273.46M | +13.23% |
| 2017-06-30 | $2.07B | $228.02M | +12.40% |
| 2016-06-30 | $1.84B | $159.80M | +9.52% |
| 2015-06-30 | $1.68B | $123.94M | +7.97% |
| 2014-06-30 | $1.55B | $40.52M | +2.68% |
| 2013-06-30 | $1.51B | $145.94M | +10.66% |
| 2012-06-30 | $1.37B | $125.37M | +10.08% |
| 2011-06-30 | $1.24B | $150.79M | +13.80% |
| 2010-06-30 | $1.09B | $171.62M | +18.64% |
| 2009-06-30 | $920.74M | $85.34M | +10.22% |
| 2008-06-30 | $835.40M | $119.07M | +16.62% |
| 2007-06-30 | $716.33M | $109.34M | +18.01% |
| 2006-06-30 | $607.00M | $181.49M | +42.65% |
| 2005-06-30 | $425.51M | $86.17M | +25.39% |
| 2004-06-30 | $339.34M | $65.77M | +24.04% |
| 2003-06-30 | $273.57M | $69.49M | +34.05% |
| 2002-06-30 | $204.08M | $48.92M | +31.53% |
| 2001-06-30 | $155.16M | $39.54M | +34.20% |
| 2000-06-30 | $115.62M | $26.99M | +30.45% |
| 1999-06-30 | $88.63M | $22.11M | +33.24% |
| 1998-06-30 | $66.52M | $17.34M | +35.26% |
| 1997-06-30 | $49.18M | $14.62M | +42.30% |
| 1996-06-30 | $34.56M | $11.06M | +47.07% |
| 1995-06-30 | $23.50M | $9.64M | +69.60% |
| 1994-06-30 | $13.86M | N/A | N/A |
Resmed Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.